Related Experiment Video
Updated: Aug 11, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
Published on: August 18, 2014
Efficacy of tolterodine as a first-line treatment for non-neurogenic voiding dysfunction in children
Semih Ayan1, Kemal Kaya, Kahraman Topsakal
1Department of Urology, Medical Faculty, Cumhuriyet University, Sivas, Turkey. sayan@cumhuriyet.edu.tr
Insights
First-line treatment with tolterodine and behavioral modification significantly improved symptoms in children with dysfunctional voiding. This approach offers a safe and effective alternative to invasive evaluations for pediatric voiding dysfunction.
Area of Science:
- Pediatric Urology
- Pharmacology
- Behavioral Therapy
Background:
- Non-neurogenic voiding dysfunction is common in children.
- Current treatment often involves invasive investigations.
- A need exists for effective first-line, non-invasive therapies.
Purpose of the Study:
- To evaluate tolterodine combined with behavioral modification as a first-line treatment for pediatric voiding dysfunction.
- To assess the efficacy of this combined approach before resorting to invasive evaluations.
- To determine if this treatment is suitable for children without neurological or anatomical abnormalities.
Main Methods:
- A study involving 44 children (30 girls, 14 boys) with voiding dysfunction.
- Noninvasive evaluation including history, urinalysis, and imaging.
- Treatment with tolterodine (1 mg twice daily) and behavioral modifications (timed voiding, pelvic floor relaxation).
- Dysfunctional Voiding Symptom Score (DVSS) assessed at baseline and 3 months.
Main Results:
- The mean DVSS significantly decreased from 14.0 to 6.68 after treatment (P < 0.001).
- Both girls and boys showed significant improvements in DVSS scores.
- The treatment was well-tolerated in the pediatric population.
Conclusions:
- Tolterodine and behavioral modification are effective first-line treatments for pediatric voiding dysfunction.
- This combined therapy can be recommended before invasive investigations.
- The DVSS is a reliable tool for monitoring treatment outcomes in children with voiding dysfunction.
Objective:
To assess the effect of antimuscarinic treatment with tolterodine combined with behavioural modification as a first-line treatment, before invasive investigation, in children with non-neurogenic voiding dysfunction but no obvious anatomical or neurogenic cause.
Patients And Methods:
The study comprised 44 children presenting with voiding dysfunction (30 girls and 14 boys, mean age 7 years, range 5-14); all had a noninvasive evaluation consisting of a history, urine analysis, renal and bladder ultrasonography and physical examination, with specific emphasis on the voiding pattern. Anticholinergic treatment with tolterodine (1 mg twice daily) was started in all patients; they were also informed about conservative management, including timed voiding, double voiding and relaxation of the pelvic floor during voiding. At the start and after 3 months, the dysfunctional voiding symptom score (DVSS) was completed twice by all patients.
Results:
For all patients the mean (sd) DVSS was 14.0 (2.67) and 6.68 (3.67) before and after treatment, respectively; the difference was statistically significant (P < 0.001). The mean scores for girls and boys, respectively, were 13.8 (2.79) and 14.5 (2.44) before and 6.43 (3.79) and 7.50 (3.34) after treatment.
Conclusion:
Tolterodine combined with behavioural modification for dysfunctional voiding in children with no neurological or anatomical abnormality can be recommended as a first-line treatment before invasive evaluation. Additionally, the DVSS appears to provide accurate and objective data for monitoring the effect of treatment in such children.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
The Micturition Reflex
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urodynamic Studies: Uroflowmetry

